CBD Products Related News
Study shows that pharmaceutical CBD is best for reducing seizures
A new study has shown that ‘not all medical cannabis is the same’ by demonstrating how artisanal CBD is not as effective as pharmaceutical...
New CBD and CBG ‘micropearl’ helps with controlled cannabis dosing
A new CBD and CBG solid ‘micropearl’ cannabis concentrate product, aimed at helping patients and consumers with controlled cannabis dosing, has received a patent...
New era in preparation of water-soluble nanoemulsion for CBD
Pressure BioSciences has announced the official opening of its new Ultra Shear Technology™ (UST™) Demonstration Laboratory which will be developing water-soluble nanoemulsions for CBD.
The...
Global nanoemulsion market growth contributes to cannabis industry
New research has predicted an increased growth in the global nanoemulsion market.
Transparency Market Research (TMR) is predicting an increased growth in the global nanoemulsion market.
Valued at...
Cann-Expo: production and manufacture of medical cannabis event
Set to become the leading international B2B commercial science event for medical cannabis, the Cann-Expo is launching in Athens, October 21-22.
Cann-Expo knows the global medical cannabis industry is maturing,...
CBD consumption to rise across the treatment of neurological conditions
Research shows that CBD consumption for the treatment of neurological conditions is set to rise.
With an exponential rise in the availability of CBD products...
Cannabis edibles are leading Canada’s cannabis market in 2020
Cannabis edibles and drinkables are already leading Canada's legal cannabis market in 2020.
It has now been more than a year since cannabis was legalised...
Study reveals difference between labelled and actual CBD potency
A scientific study has revealed differences between the CBD potency labelled on products and actual potency when measured.
GemmaCert has revealed the results of a...
CBD in Europe report: making the single market real
Pan-European Association, ACTIVE has launched its first English-speaking report: CBD in Europe — Making the Single Market Real.
The report is the second ACTIVE report,...
B3 Labs responds to FSA CBD deadline announcement
Last week The Food Standards Agency (FSA) formally issued a definitive timeline for Novel Food applications setting a deadline for the 31 March 2021...
Global platform launched for pharmaceutical-grade cannabis extracts
Clever Leaves has announced that it has launched its direct-to-business sales platform, Clever Leaves 360, for pharmceutical-grade cannabis extract products.
Clever Leaves, a leading multi-national operator...
Valens Company to export first international cannabis products to Australia
Valens GroWorks has announced its first international shipments of white label products to customers in Australia.
Based on the purchase orders received, the initial shipments...
CannaPro: the only solution for CBD is a cannabis regulation authority
Following the issuing of the Food Standards Agency’s (FSA) CBD safety advice, a UK cannabis body, CannaPro, has suggested that the solution for the...
CBD products do not fall under scope of Novel Food schedule says CTA
The UK Cannabis Trades Association has responded to yesterday’s FSA announcement – stating that CBD does not fall under the scope of the Novel...
CBD infused products continue to bolster global billion dollar market growth
The global CBD size is projected to continue its seemingly ever accelerating growth and is expected to reach $23.6bn, expanding at a CAGR of...
CBD education: 71% of Brits do not know if CBD has drug-like effects
A new survey has revealed that the majority of Brits are still unsure as to CBD's effects.
CBD (cannabidiol) is one of the most popular...
FSA issues first ever CBD safety advice and sets deadline for businesses
The Food Standards Agency (FSA) has issued its first ever CBD safety advice for consumers, and a stark warning to manufacturers.
Today the FSA has...
Revolutionising medicine: from methadone man to cannabis chief
The inventor of liquid methadone, Stephen Goldner, has now created a new, cannabis-derived medicine – a water-soluble CBD tablet.
In 1973, after working at the...
CBD’s therapeutic benefits help loosen regulatory constraints
Most regions that have approved medical cannabis typically see doctors prescribe CBD-based medications to their patients.
CBD's therapeutic benefits have thrust the compound into the...
CanaQuest awaits Health Canada approval for sales and export
CanaQuest Medical Corp has announced it has applied to Health Canada for approval to produce, sell and export Mentabinol® (THC based, all-natural formulation) under...
